## Clinical Presentation Acute RUQ pain + fever (38.5°C) + jaundice = **Charcot's Triad** → **Acute Cholangitis** with suspected choledocholithiasis. Bedside ultrasound confirms dilated CBD (8 mm) and echogenic material in the gallbladder. ## Why Immediate ERCP with Sphincterotomy is the Correct Answer **Key Point:** In **acute cholangitis**, the priority is **biliary decompression and drainage** — not further diagnostic imaging. ERCP serves both a diagnostic AND therapeutic role simultaneously (visualizes the CBD, extracts stones, performs sphincterotomy for drainage). **High-Yield:** According to the **Tokyo Guidelines (TG18)** for acute cholangitis management: - Acute cholangitis with Charcot's triad requires **urgent biliary drainage** within 24–48 hours (moderate severity) or immediately (severe/Reynold's pentad). - **ERCP with sphincterotomy** is the first-line intervention — it is both diagnostic and therapeutic. - MRCP is appropriate when the **diagnosis is uncertain** and the patient is **hemodynamically stable without cholangitis**. | Scenario | Appropriate Next Step | |---|---| | Suspected CBD stone, **no cholangitis**, stable patient | MRCP first (non-invasive confirmation) | | **Acute cholangitis** (Charcot's triad) with dilated CBD | **Immediate ERCP** (diagnostic + therapeutic) | | Severe cholangitis (Reynold's pentad) | Emergency ERCP or percutaneous drainage | ## Why NOT MRCP First in This Case? MRCP is appropriate for **elective/stable** patients with suspected choledocholithiasis but **without active cholangitis**. In this patient, the clinical picture is acute cholangitis — a potentially life-threatening condition requiring urgent intervention. Delaying ERCP to obtain MRCP wastes critical time and increases morbidity. MRCP is a purely diagnostic tool with **no therapeutic capability**. **Clinical Pearl:** In acute cholangitis where biliary obstruction must be relieved urgently, ERCP is preferred because it simultaneously confirms the diagnosis and provides treatment (stone extraction, sphincterotomy, stent placement). The dilated CBD (8 mm) on ultrasound already provides sufficient evidence of biliary obstruction to proceed directly to ERCP. [Harrison's Principles of Internal Medicine, 21e, Ch. 310; Tokyo Guidelines 2018] ## Why Not the Other Options? - **MRCP:** Appropriate for stable patients with diagnostic uncertainty — NOT when acute cholangitis is already clinically evident and urgent drainage is needed. - **CT abdomen with IV contrast:** Poor sensitivity for small CBD stones; used to assess complications (pancreatitis, perforation), not for primary management of cholangitis. - **HIDA scan:** Assesses biliary excretion and cystic duct patency; does not visualize stones and has no role in acute cholangitis management. **Mnemonic:** In **Cholangitis = ERCP urgently**; in **Choledocholithiasis without cholangitis = MRCP first, then ERCP if confirmed**. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.